• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Redhill Biopharma Ltd

+ Add to Watchlist

RDHL:IT

535.00 ILs 3.70 0.70%

As of 05:37:36 ET on 07/14/2014.

Snapshot for Redhill Biopharma Ltd (RDHL)

Open: 531.30 Day's Range: 530.00 - 541.00 Volume: 40,295
Previous Close: 531.30 52wk Range: 323.00 - 680.00 1-Yr Rtn: +44.17%

Stock Chart for RDHL

No chart data available.
  • RDHL:IT 534.00
  • 1D
  • 1M
  • 1Y
531.30
Interactive RDHL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RDHL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -0.1228
Est. EPS (USD) (12/2014) -1.1100
Est. PEG Ratio -
Market Cap (M ILS) 466.45
Shares Outstanding (M) 87.79
30 Day Average Volume 262,109
Price/Book (mrq) 3.6861
Price/Sale (ttm) 18.5602
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RDHL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RDHL

Redhill Biopharma Ltd focuses primarily on the development and acquisition of therapeutic candidates acquired through asset purchases or in-licensing. The Company acquires, in-licenses and develops patent-protected new formulations and combinations of existing drugs in advanced stages of development.

Dror Ben-AsherChairman/CEOOri ShiloDpty CEO:Finance & Operations
Uri Hananel AharonChief Accounting OfficerGuy GoldbergChief Business Officer
More Company Profile & Key Executives for RDHL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil